134 related articles for article (PubMed ID: 1982451)
1. Immunological abnormalities in family members of patients with IgA nephropathy.
Miyazaki M
Jpn J Med; 1990; 29(5):469-77. PubMed ID: 1982451
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities of the IgA immune system in members of unrelated pedigrees from patients with IgA nephropathy.
Schena FP; Scivittaro V; Ranieri E; Sinico R; Benuzzi S; Di Cillo M; Aventaggiato L
Clin Exp Immunol; 1993 Apr; 92(1):139-44. PubMed ID: 8467558
[TBL] [Abstract][Full Text] [Related]
3. CD4 subsets in IgA nephropathy.
Kashem A; Yamauchi F; Yano N; Miyazaki M; Endoh M; Nomoto Y; Sakai H
Tokai J Exp Clin Med; 1992 Dec; 17(5-6):173-7. PubMed ID: 1285308
[TBL] [Abstract][Full Text] [Related]
4. [Peripheral blood IgA bearing cells in children with Henoch-Schönlein purpura nephritis and IgA nephropathy. Relationship between IgA bearing cells and clinico-pathological findings or T alpha 4 cells].
Kubota R
Nihon Jinzo Gakkai Shi; 1992 Nov; 34(11):1149-59. PubMed ID: 1363477
[TBL] [Abstract][Full Text] [Related]
5. Subpopulations of T alpha cells in patients with IgA nephropathy: correlation between T alpha 4 cells and in vitro IgA production.
Yasumoto Y; Suga T; Miura M; Endoh M; Nomoto H; Tomino Y; Nomoto Y; Sakai H
Clin Immunol Immunopathol; 1989 May; 51(2):232-9. PubMed ID: 2784755
[TBL] [Abstract][Full Text] [Related]
6. Glomerular Fc alphaR expression and disease activity in IgA nephropathy.
Kashem A; Endoh M; Yano N; Yamauchi F; Nomoto Y; Sakai H; Kurokawa K
Am J Kidney Dis; 1997 Sep; 30(3):389-96. PubMed ID: 9292568
[TBL] [Abstract][Full Text] [Related]
7. Immunological studies of IgA nephropathy in blacks reveal elevations of serum IgA2 as well as IgA1.
Crowley-Nowick PA; Bull R; van den Wall Bake AW; Kulhavy L; Julian BA; Jackson S
Nephrol Dial Transplant; 1994; 9(9):1324-9. PubMed ID: 7816300
[TBL] [Abstract][Full Text] [Related]
8. Murine Models of Human IgA Nephropathy.
Suzuki H; Suzuki Y
Semin Nephrol; 2018 Sep; 38(5):513-520. PubMed ID: 30177023
[TBL] [Abstract][Full Text] [Related]
9. Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy.
Vuong MT; Hahn-Zoric M; Lundberg S; Gunnarsson I; van Kooten C; Wramner L; Seddighzadeh M; Fernström A; Hanson LÅ; Do LT; Jacobson SH; Padyukov L
Kidney Int; 2010 Dec; 78(12):1281-7. PubMed ID: 20811333
[TBL] [Abstract][Full Text] [Related]
10. Expression and correlation analysis of IL-4, IFN-γ and FcαRI in tonsillar mononuclear cells in patients with IgA nephropathy.
Chen X; Liu H; Peng Y; He L; Zhang Y; Xie Y; Peng X; Liu C; Liu F
Cell Immunol; 2014; 289(1-2):70-5. PubMed ID: 24732061
[TBL] [Abstract][Full Text] [Related]
11. Aberrant T-regulation in rheumatoid arthritis and IgA nephropathy affects CD5+ and CD5- B lymphocytes equally.
Jones BM; Cheng IK; Wong RW
Clin Exp Immunol; 1991 Nov; 86(2):212-8. PubMed ID: 1718638
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-155-induced T lymphocyte subgroup drifting in IgA nephropathy.
Yang L; Zhang X; Peng W; Wei M; Qin W
Int Urol Nephrol; 2017 Feb; 49(2):353-361. PubMed ID: 27796698
[TBL] [Abstract][Full Text] [Related]
13. Immune abnormalities and clinical course in childhood IgA nephropathy.
Iijima K; Yoshikawa N; Shiozawa S; Matsuyama S; Kobayashi K; Yoshiya K; Nakamura H
Nephron; 1990; 56(3):255-60. PubMed ID: 2077407
[TBL] [Abstract][Full Text] [Related]
14. Oligoclonally expanding gammadelta T lymphocytes induce IgA switching in IgA nephropathy.
Toyabe S; Harada W; Uchiyama M
Clin Exp Immunol; 2001 Apr; 124(1):110-7. PubMed ID: 11359449
[TBL] [Abstract][Full Text] [Related]
15. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
[TBL] [Abstract][Full Text] [Related]
16. Increase of CD23-positive cells in peripheral blood from patients with IgA nephropathy and non-IgA proliferative glomerulonephritis.
Yano N; Miyazaki M; Endoh M; Kuramoto T; Eguchi K; Yagame M; Nomoto Y; Sakai H
Nephron; 1992; 60(4):404-10. PubMed ID: 1533901
[TBL] [Abstract][Full Text] [Related]
17. Sequential study of the IgA system in relapsing IgA nephropathy.
Feehally J; Beattie TJ; Brenchley PE; Coupes BM; Mallick NP; Postlethwaite RJ
Kidney Int; 1986 Dec; 30(6):924-31. PubMed ID: 3493382
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-induced immunoglobulin production in primary IgA nephropathy.
van den Wall Bake AW; Crowley-Nowick PA; Kulhavy R; Hermans J; Jackson S; Julian BA; Mestecky J
Am J Kidney Dis; 1992 Dec; 20(6):611-7. PubMed ID: 1462991
[TBL] [Abstract][Full Text] [Related]
19. [New immunopathogenic aspects of IgA nephropathy].
Hernando L; González-Cabrero J; García-Hoyo R; Hernando P; Egido J
Bull Acad Natl Med; 1990 May; 174(5):549-59. PubMed ID: 2249143
[TBL] [Abstract][Full Text] [Related]
20. In vitro immunoglobulin production in relatives of patients with IgA nephropathy.
Scivittaro V; Ranieri E; Di Cillo M; Aventaggiato L; Emancipator SN; Schena FP
Clin Nephrol; 1994 Jul; 42(1):1-8. PubMed ID: 7923960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
